相关实验视频
Updated: Jan 15, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.7K
SWAP70通过内皮CAV1核转位促进动脉样硬化
Tianyu Gao1,2, Xinxin Li1,2, Wei Zhang1,2
1School of Public Health and Emergency Management, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China (T.G., X.L., W.Z., Y.Y., Y.L., F.L., B.B., D.G.).
Circulation research
|January 14, 2026
概括
交换关联蛋白70 (SWAP70) 通过促进卡韦林-1核转位来调节内皮炎症和动脉样硬化. 准这种途径为心血管疾病提供了一个新的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 内皮细胞生物学 内皮细胞生物学
背景情况:
- 动脉样硬化是冠状动脉疾病的主要原因,源于血液流动干扰和慢性内皮炎症.
- 交换关联蛋白70 (SWAP70) 是基因与冠状动脉疾病相关的,但其在动脉动脉产生中的作用尚不清楚.
研究的目的:
- 研究SWAP70在血管炎症和动脉样硬化斑块发育中的功能作用.
- 阐明SWAP70影响内皮细胞对机械应激和炎症反应的分子机制.
主要方法:
- 利用内皮细胞特异性的Swap70过度表达和淘汰赛小鼠模型.
- 在人类静脉内皮细胞中使用了lentiviral过度表达和siRNA敲击.
- 在振荡剪切应力和细胞因子刺激下进行了体外测定,以及包括共免疫沉降和RNA测序在内的机制研究.
主要成果:
- 在振荡式剪切应力和人类动脉样硬化斑块下,SWAP70的表达增加.
- SWAP70促进了caveolin-1核转位,增强了炎症基因表达.
- 内皮特异性Swap70删除在体内减轻了动脉样硬化,而过度表达加剧了炎症.
结论:
- 通过新的SWAP70-CAV1信号轴,SWAP70作为内皮炎症和动脉样硬化的机械反应调节器.
- 针对SWAP70-CAV1相互作用,为动脉样硬化心血管疾病提供了潜在的治疗策略.
相关概念视频
01:30Atherosclerosis I: Introduction
904
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
904
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
458
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
458
01:23Atherosclerosis IV: Nursing Management
363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
01:38Inflammation
61.6K
Overview
61.6K
01:26Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366